Complete News World


The EMA analyzes rare cases of Guillain-Barré syndrome following vaccination with AstraZeneca

The European Medicines Agency (EMA) is analyzing rare cases of Guillain-Barré syndrome in people who received the Covid-19 vaccine from AstraZenec, after they asked the pharmacist for more information, Reuters provides.

This syndrome is a rare neurological condition in which the body’s immune system attacks the protective lining of nerve fibers.

Most cases appear a few days or weeks after infection with a bacterial or viral infection. There are also cases that occur after respiratory or intestinal infections or after vaccination.

The EMA and other regulators have already evaluated the potential for rare blood clotting diseases to be linked to Covid-19 vaccines, including AstraZeneca vaccines. Research that has now been strengthened with this syndrome, in particular.

In addition, the European regulator also announced that it is investigating cases of carditis in those who have been vaccinated with Pfizer and Moderne injections. Both vaccines use new mRNA technology to create immunity to the new coronavirus.

See also  This typical autumn food greatly enhances digestion